USD 0.01
(-14.81%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 625 Thousand USD | 0.0% |
2022 | 625 Thousand USD | 22.59% |
2021 | 509.84 Thousand USD | 0.0% |
2020 | - USD | -100.0% |
2019 | 3933.20 USD | 0.0% |
2018 | 3933.20 USD | 0.0% |
2016 | 3.9 Million USD | 60303.28% |
2015 | 6461.57 USD | -90.61% |
2014 | 68.81 Thousand USD | 0.0% |
2007 | 1.07 Million USD | 775.81% |
2006 | 122.46 Thousand USD | 0.0% |
2005 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 FY | 625 Thousand USD | 0.0% |
2023 Q3 | 625 Thousand USD | 0.0% |
2023 Q4 | 625 Thousand USD | 0.0% |
2023 Q1 | 625 Thousand USD | 0.0% |
2023 Q2 | 625 Thousand USD | 0.0% |
2022 Q2 | 569.33 Thousand USD | 5.71% |
2022 Q4 | 625 Thousand USD | 3.79% |
2022 FY | 625 Thousand USD | 22.59% |
2022 Q1 | 538.6 Thousand USD | 5.64% |
2022 Q3 | 602.18 Thousand USD | 5.77% |
2021 Q1 | - USD | 0.0% |
2021 FY | 509.84 Thousand USD | 0.0% |
2021 Q4 | 509.84 Thousand USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2020 FY | - USD | -100.0% |
2019 FY | 3933.20 USD | 0.0% |
2018 FY | 3933.20 USD | 0.0% |
2016 FY | 3.9 Million USD | 60303.28% |
2015 FY | 6461.57 USD | -90.61% |
2014 FY | 68.81 Thousand USD | 0.0% |
2008 Q2 | 82.49 Thousand USD | -92.23% |
2008 Q3 | 65.06 Thousand USD | -21.13% |
2008 Q1 | 1.06 Million USD | -1.01% |
2007 FY | 1.07 Million USD | 775.81% |
2007 Q4 | 1.07 Million USD | 720.98% |
2007 Q1 | 170.51 Thousand USD | 39.23% |
2007 Q3 | 130.64 Thousand USD | -10.27% |
2007 Q2 | 145.6 Thousand USD | -14.61% |
2006 Q4 | 122.46 Thousand USD | 107.7% |
2006 Q2 | 68.88 Thousand USD | -25.29% |
2006 FY | 122.46 Thousand USD | 0.0% |
2006 Q1 | 92.2 Thousand USD | 0.0% |
2006 Q3 | 58.96 Thousand USD | -14.4% |
2005 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
American Medical Technologies Inc. | - USD | -Infinity% |
Ansell Limited | 705.27 Million USD | 99.911% |
Ansell Limited | 706.6 Million USD | 99.912% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 22.41 Million USD | 97.211% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | - USD | -Infinity% |
ConvaTec Group Plc | 1.22 Billion USD | 99.949% |
ConvaTec Group Plc | 1.22 Billion USD | 99.949% |
Encision Inc. | 67.33 Thousand USD | -828.181% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | - USD | -Infinity% |
Innovative MedTech Inc. | 382.83 Thousand USD | -63.255% |
LifePoint, Inc. | 151.73 Thousand USD | -311.905% |
Medite Cancer Diagnostics, Inc. | 4.91 Million USD | 87.281% |
Paradigm Medical Industries, Inc. | 615 Thousand USD | -1.626% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | - USD | -Infinity% |
Reflect Scientific, Inc. | 179.96 Thousand USD | -247.294% |
SmileDirectClub, Inc. | 849.37 Million USD | 99.926% |
Sector 10, Inc. | - USD | -Infinity% |
Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | 99.703% |
SheerVision, Inc. | - USD | -Infinity% |
United Health Products, Inc. | 48.48 Thousand USD | -1188.952% |
Vasamed, Inc. | 18.95 Thousand USD | -3198.153% |
Wearable Health Solutions, Inc. | 18.46 Thousand USD | -3284.232% |
Yubo International Biotech Limited | 390.44 Thousand USD | -60.074% |